<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-07-01" modified="2020-10-07" version="176">
<accession>P31995</accession>
<accession>O00523</accession>
<accession>O00524</accession>
<accession>O00525</accession>
<name>FCG2C_HUMAN</name>
<protein>
<recommendedName>
<fullName>Low affinity immunoglobulin gamma Fc region receptor II-c</fullName>
<shortName>IgG Fc receptor II-c</shortName>
</recommendedName>
<alternativeName>
<fullName>CDw32</fullName>
</alternativeName>
<alternativeName>
<fullName>Fc-gamma RII-c</fullName>
<shortName>Fc-gamma-RIIc</shortName>
<shortName>FcRII-c</shortName>
</alternativeName>
<cdAntigenName>CD32</cdAntigenName>
</protein>
<gene>
<name type="primary">FCGR2C</name>
<name type="synonym">CD32</name>
<name type="synonym">FCG2</name>
<name type="synonym">IGFR2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="EMBO J." volume="8" first="3657" last="3666">
<title>Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium.</title>
<authorList>
<person name="Stuart S.G."/>
<person name="Simister N.E."/>
<person name="Clarkson S.B."/>
<person name="Kacinski B.M."/>
<person name="Shapiro M."/>
<person name="Mellman I."/>
</authorList>
<dbReference type="PubMed" id="2531080"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1989.tb08540.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IIC1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Blood" volume="91" first="2369" last="2380">
<title>Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene.</title>
<authorList>
<person name="Metes D."/>
<person name="Ernst L.K."/>
<person name="Chambers W.H."/>
<person name="Sulica A."/>
<person name="Herberman R.B."/>
<person name="Morel P.A."/>
</authorList>
<dbReference type="PubMed" id="9516136"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS IIC1; IIC2; IIC3 AND IIC4)</scope>
<source>
<tissue>Natural killer cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="4735" last="4743">
<title>In vivo and in vitro specificity of protein tyrosine kinases for immunoglobulin G receptor (FcgammaRII) phosphorylation.</title>
<authorList>
<person name="Bewarder N."/>
<person name="Weinrich V."/>
<person name="Budde P."/>
<person name="Hartmann D."/>
<person name="Flaswinkel H."/>
<person name="Reth M."/>
<person name="Frey J."/>
</authorList>
<dbReference type="PubMed" id="8756631"/>
<dbReference type="DOI" id="10.1128/mcb.16.9.4735"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-294 AND TYR-310</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2013" name="Protein Eng. Des. Sel." volume="26" first="589" last="598">
<title>Engineered antibody Fc variant with selectively enhanced FcgammaRIIb binding over both FcgammaRIIa(R131) and FcgammaRIIa(H131).</title>
<authorList>
<person name="Mimoto F."/>
<person name="Katada H."/>
<person name="Kadono S."/>
<person name="Igawa T."/>
<person name="Kuramochi T."/>
<person name="Muraoka M."/>
<person name="Wada Y."/>
<person name="Haraya K."/>
<person name="Miyazaki T."/>
<person name="Hattori K."/>
</authorList>
<dbReference type="PubMed" id="23744091"/>
<dbReference type="DOI" id="10.1093/protein/gzt022"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.86 ANGSTROMS) OF 45-217</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-187</scope>
</reference>
<comment type="function">
<text>Receptor for the Fc region of complexed immunoglobulins gamma. Low affinity receptor. Involved in a variety of effector and regulatory functions such as phagocytosis of immune complexes and modulation of antibody production by B-cells.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1396036">
<id>P31995</id>
</interactant>
<interactant intactId="EBI-1395983">
<id>P02741</id>
<label>CRP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1396036">
<id>P31995</id>
</interactant>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform IIC4</molecule>
<subcellularLocation>
<location evidence="7">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform IIC3</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform IIC2</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform IIC1</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P31995-1</id>
<name>IIC1</name>
<name>C1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P31995-2</id>
<name>IIC2</name>
<sequence type="described" ref="VSP_002646"/>
</isoform>
<isoform>
<id>P31995-3</id>
<name>IIC3</name>
<sequence type="described" ref="VSP_002645"/>
</isoform>
<isoform>
<id>P31995-4</id>
<name>IIC4</name>
<sequence type="described" ref="VSP_002644"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Isoform IIC1 is detected in monocytes, macrophages, polymorphonuclear cells and natural killer cells.</text>
</comment>
<comment type="domain">
<text>Contains an intracytoplasmic twice repeated motif referred as immunoreceptor tyrosine-based activator motif (ITAM). These motifs are involved in triggering cell activation upon receptors aggregation.</text>
</comment>
<comment type="PTM">
<text evidence="5">Phosphorylated by SRC-type Tyr-kinases such as LYN, BLK, FYN and SYK.</text>
</comment>
<comment type="caution">
<text evidence="7">Has sometimes been attributed to correspond to FcR-IIB.</text>
</comment>
<comment type="caution">
<text evidence="7">FCGR2C is both a gene and a pseudogene in the human population, the reference genome corresponding currently to the non-functional allele with a stop codon at position 57. The sequence shown here with a Gln at that position is the one of the functional protein.</text>
</comment>
<comment type="sequence caution" evidence="7">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAA35643" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="X17652">
<property type="protein sequence ID" value="CAA35642.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X17652">
<property type="protein sequence ID" value="CAA35643.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U90938">
<property type="protein sequence ID" value="AAC12807.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U90939">
<property type="protein sequence ID" value="AAC12808.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U90940">
<property type="protein sequence ID" value="AAC12809.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U90941">
<property type="protein sequence ID" value="AAC12810.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="PIR" id="S06946">
<property type="entry name" value="S06946"/>
</dbReference>
<dbReference type="RefSeq" id="NP_963857.3">
<property type="nucleotide sequence ID" value="NM_201563.5"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011507594.1">
<property type="nucleotide sequence ID" value="XM_011509292.2"/>
</dbReference>
<dbReference type="PDB" id="3WJL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.86"/>
<property type="chains" value="C=45-217"/>
</dbReference>
<dbReference type="PDBsum" id="3WJL"/>
<dbReference type="SMR" id="P31995"/>
<dbReference type="BioGRID" id="114556">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="IntAct" id="P31995">
<property type="interactions" value="8"/>
</dbReference>
<dbReference type="DrugBank" id="DB00054">
<property type="generic name" value="Abciximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00092">
<property type="generic name" value="Alefacept"/>
</dbReference>
<dbReference type="DrugBank" id="DB00087">
<property type="generic name" value="Alemtuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00074">
<property type="generic name" value="Basiliximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00002">
<property type="generic name" value="Cetuximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00111">
<property type="generic name" value="Daclizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00095">
<property type="generic name" value="Efalizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00005">
<property type="generic name" value="Etanercept"/>
</dbReference>
<dbReference type="DrugBank" id="DB00056">
<property type="generic name" value="Gemtuzumab ozogamicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00028">
<property type="generic name" value="Human immunoglobulin G"/>
</dbReference>
<dbReference type="DrugBank" id="DB00078">
<property type="generic name" value="Ibritumomab tiuxetan"/>
</dbReference>
<dbReference type="DrugBank" id="DB00075">
<property type="generic name" value="Muromonab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00108">
<property type="generic name" value="Natalizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00110">
<property type="generic name" value="Palivizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00081">
<property type="generic name" value="Tositumomab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00072">
<property type="generic name" value="Trastuzumab"/>
</dbReference>
<dbReference type="GlyGen" id="P31995">
<property type="glycosylation" value="4 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P31995"/>
<dbReference type="PhosphoSitePlus" id="P31995"/>
<dbReference type="BioMuta" id="FCGR2C"/>
<dbReference type="DMDM" id="399478"/>
<dbReference type="jPOST" id="P31995"/>
<dbReference type="MassIVE" id="P31995"/>
<dbReference type="MaxQB" id="P31995"/>
<dbReference type="PeptideAtlas" id="P31995"/>
<dbReference type="PRIDE" id="P31995"/>
<dbReference type="ProteomicsDB" id="54825">
<molecule id="P31995-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54826">
<molecule id="P31995-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54827">
<molecule id="P31995-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54828">
<molecule id="P31995-4"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P31995-4">
<molecule id="P31995-4"/>
</dbReference>
<dbReference type="GeneID" id="9103"/>
<dbReference type="KEGG" id="hsa:9103"/>
<dbReference type="CTD" id="9103"/>
<dbReference type="DisGeNET" id="9103"/>
<dbReference type="GeneCards" id="FCGR2C"/>
<dbReference type="HGNC" id="HGNC:15626">
<property type="gene designation" value="FCGR2C"/>
</dbReference>
<dbReference type="MalaCards" id="FCGR2C"/>
<dbReference type="MIM" id="612169">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P31995"/>
<dbReference type="Orphanet" id="3002">
<property type="disease" value="Immune thrombocytopenia"/>
</dbReference>
<dbReference type="InParanoid" id="P31995"/>
<dbReference type="KO" id="K16824"/>
<dbReference type="PhylomeDB" id="P31995"/>
<dbReference type="PathwayCommons" id="P31995"/>
<dbReference type="BioGRID-ORCS" id="2213">
<property type="hits" value="4 hits in 868 CRISPR screens"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="9103">
<property type="hits" value="0 hits in 53 CRISPR screens"/>
</dbReference>
<dbReference type="Pharos" id="P31995">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P31995"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="RNAct" id="P31995">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019864">
<property type="term" value="F:IgG binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050776">
<property type="term" value="P:regulation of immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0390">IgG-binding protein</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="2">
<location>
<begin position="1"/>
<end position="42"/>
</location>
</feature>
<feature type="chain" description="Low affinity immunoglobulin gamma Fc region receptor II-c" id="PRO_0000015148">
<location>
<begin position="43"/>
<end position="323"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="43"/>
<end position="223"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="224"/>
<end position="246"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="247"/>
<end position="323"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="48"/>
<end position="127"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="131"/>
<end position="213"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC-type Tyr-kinases" evidence="5">
<location>
<position position="294"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC-type Tyr-kinases" evidence="5">
<location>
<position position="310"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="106"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="180"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="187"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 4">
<location>
<begin position="71"/>
<end position="113"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 4">
<location>
<begin position="152"/>
<end position="196"/>
</location>
</feature>
<feature type="splice variant" description="In isoform IIC4." id="VSP_002644" evidence="6">
<original>APSSSPMGIIVAVVTGIAVAAIVAAVVALIYCRKKRISANSTDPVKAAQFEPPGRQMIAIRKRQPEETNNDYETADGGYMTLNPRAPTDDDKNIYLTLPPNDHVNSNN</original>
<variation>GPRLRTAAKQSSLVGAEVP</variation>
<location>
<begin position="216"/>
<end position="323"/>
</location>
</feature>
<feature type="splice variant" description="In isoform IIC3." id="VSP_002645" evidence="6">
<original>NSTDPVKAAQFEPPGRQMIAIRKRQPEETNNDYETADGGYMTLNPRAPTDDDKNIYLTLPPNDHVNSNN</original>
<variation>TWTSNDCHQKETT</variation>
<location>
<begin position="255"/>
<end position="323"/>
</location>
</feature>
<feature type="splice variant" description="In isoform IIC2." id="VSP_002646" evidence="6">
<original>PPGRQMIAIRKRQPEETNNDYETADGGYMTLNPRAPTDDDKNIYLTLPPNDHVNSNN</original>
<variation>MLSCSHLDVK</variation>
<location>
<begin position="267"/>
<end position="323"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC12810." ref="2" evidence="7">
<original>R</original>
<variation>K</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC12809." ref="2" evidence="7">
<original>T</original>
<variation>I</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="51"/>
<end position="53"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="59"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="66"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="83"/>
<end position="86"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="89"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="96"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="105"/>
<end position="107"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="109"/>
<end position="114"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="116"/>
<end position="119"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="124"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="131"/>
<end position="136"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="140"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="148"/>
<end position="154"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="155"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="161"/>
<end position="167"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="170"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="180"/>
<end position="185"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="188"/>
<end position="190"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="192"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="203"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="210"/>
<end position="215"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WJL"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23744091"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8756631"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9516136"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000305"/>
<sequence length="323" mass="35578" checksum="DC4C1A22A0DE4572" modified="1993-07-01" version="1" precursor="true">MGILSFLPVLATESDWADCKSPQPWGHMLLWTAVLFLAPVAGTPAAPPKAVLKLEPQWINVLQEDSVTLTCRGTHSPESDSIQWFHNGNLIPTHTQPSYRFKANNNDSGEYTCQTGQTSLSDPVHLTVLSEWLVLQTPHLEFQEGETIVLRCHSWKDKPLVKVTFFQNGKSKKFSRSDPNFSIPQANHSHSGDYHCTGNIGYTLYSSKPVTITVQAPSSSPMGIIVAVVTGIAVAAIVAAVVALIYCRKKRISANSTDPVKAAQFEPPGRQMIAIRKRQPEETNNDYETADGGYMTLNPRAPTDDDKNIYLTLPPNDHVNSNN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

